Pilot-Scale Clinical Trials of Kibow Biotics® in Chronic Kidney Failure

Completed

Conditions studied: Chronic Kidney Failure

In brief

The bowel can serve as a complement to the kidneys' excretory function A specifically formulated probiotic product comprised of defined and tested microbial strains may afford renoprotection in what has been called "enteric dialysis"® Confirm the alleviation of uremic syndrome hypothesis Determine the outcome of probiotics treatment Confirm U.S. FDA's Generally Recognized As Safe (GRAS) status - if needed

Key facts

Study ID
NCT00760162
Run by
Kibow Pharma
People needed
180
Starts
2007-08-01
Expected to finish
2009-08-01
Last updated by the study team
2019-08-20

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.